Samsara BioCapital, L.P.

13F Holdings History for Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Symbol
KLRS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
11.4M shares
Security Ownership
61.2%

Samsara BioCapital, L.P. ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

2025-03-25 - Samsara BioCapital, L.P. has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 11.4M shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS). This represents 61.2% percent ownership of the company.